Compare Immunovant Inc. Common Stock (IMVT) vs MACOM Technology (MTSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs MACOM Technology — how do they compare? Immunovant Inc. Common Stock trades at $30.47 (market cap $6.25B), while MACOM Technology trades at $330.06 (market cap $24.61B). The key difference: MACOM Technology is far larger — about 3.9× Immunovant Inc. Common Stock's market cap, and MACOM Technology is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and MACOM Technology for 6 Days on average.
| IMVT | MTSI | |
|---|---|---|
Market Cap | $6.25B | $24.61B |
Volume | 1,755,411 | 1,594,575 |
Sector | Health | Technology |
52-Week High | $44.96 | $409.68 |
52-Week Low | $17.03 | $122.18 |
Typical Hold Time | 1 Days | 6 Days |
Enterprise Value | $5.35B | $24.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About MACOM Technology
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →
